BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299 | -99.9% | 5,960 | -49.6% | 0.01% | -68.9% |
| Q2 2022 | $597,000 | -13.2% | 11,819 | +9.8% | 0.04% | 0.0% |
| Q1 2022 | $688,000 | -31.0% | 10,769 | +15.6% | 0.04% | -64.0% |
| Q4 2021 | $997,000 | +232.3% | 9,312 | +219.1% | 0.12% | +212.5% |
| Q3 2021 | $300,000 | -64.4% | 2,918 | -73.0% | 0.04% | -86.0% |
| Q2 2020 | $843,000 | -44.1% | 10,813 | -58.0% | 0.29% | -55.0% |
| Q1 2020 | $1,507,000 | +237.1% | 25,763 | +350.2% | 0.64% | +561.5% |
| Q3 2018 | $447,000 | – | 5,722 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |